Connect and the Pillsbury Winthrop law firm have organized this Frameworks Workshop. Bioscience companies rely more heavily on having an effective intellectual property portfolio than do companies based on other technologies. Because it can take years to reach product commercialization, one of the greatest assets for the company is its intellectual property portfolio. Both a sword and a shield, a strong portfolio enables the company to protect the promise that it will be able to maintain a proprietary position in the market relative to its competitors. This workshop covers basic elements of developing a commercially meaningful intellectual property portfolio for a bioscience company. Online registration is here.